Showing 60,981 - 61,000 results of 125,061 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.30s Refine Results
  1. 60981

    Image3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  2. 60982

    Table4_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  3. 60983

    Table2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  4. 60984

    Table3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  5. 60985

    Neurogenesis in 12-month-old AβPP-PS1 and wild-type mice on control and specific multi-nutrient diets. by Diane Jansen (414816)

    Published 2013
    “…Post hoc analysis revealed that AβPP-PS1 mice fed the CO diet displayed a significantly decreased relative amount of Dcx+ immature neurons compared to wild-type mice on the CO diet (*<i>p</i> = 0.004). …”
  6. 60986

    Data_Sheet_1_Extramatrical Mycelium and Ectomycorrhizal Community Composition of Quercus pubescens in a Sub-Mediterranean Stress-Prone Environment.PDF by Tanja Mrak (8541582)

    Published 2021
    “…This was ascribed to a series of stress events that occurred at the site including sequential droughts and wildfire. …”
  7. 60987

    Image2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  8. 60988

    DataSheet_1_Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.pdf by Yujie Shang (11630293)

    Published 2021
    “…Two reviewers made study selection, data extraction and bias assessment independently. Risk ratios and mean difference with 95% confidence intervals were assessed by a random-effects model. …”
  9. 60989

    Image1_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG by Xianglin Pan (4441699)

    Published 2024
    “…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
  10. 60990

    DataSheet1_Efficacy and safety of danshen class injections in the treatment of coronary heart disease: a network meta-analysis.docx by Shuang Dai (1413496)

    Published 2024
    “…NMA was conducted using RevMan 5.3 and Stata 16.0 software.</p>Results<p>A total of 106 studies including 14,979 patients, involving 10,931 patients, with 5,640 in the experimental group and 5,291 in the control group. …”
  11. 60991

    Supplementary Material for: Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Ana... by Hatanaka T. (11765621)

    Published 2023
    “…The mALBI grade was classified as 1, 2a, 2b, and 3 in 10 (38.5%), 6 (23.1%), 10 (38.5%), and zero (0.0%) patients, respectively, in the Atez/Bev group and 21 (45.7%), 9 (19.6%), 15 (32.6%), and 1 (2.2%) patient in the LEN group (<i>p</i> = 0.9). …”
  12. 60992

    Model vs. WKY group KEGG pathways (Top 15). by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  13. 60993

    Behavioral data. by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  14. 60994

    OPLS-DA model parameter. by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  15. 60995

    Model vs. SHR group KEGG pathways (Top 15). by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  16. 60996

    Table 1_CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study.docx by Jingwei Yu (201422)

    Published 2025
    “…At a median follow-up of 8.5 months, the median PFS and OS were both not reached. …”
  17. 60997

    The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis by Ingrid Lindquist (262581)

    Published 2021
    “…Total periprocedural bleeding was decreased in patients who received TPO-RAs (11.6% vs 15.6%, RR 0.64, 95% CI 0.5–0.9 <i>p</i> = .01. …”
  18. 60998

    Diagnostic criteria for Alcoholic cardiomyopathy. by Fei Yan (128878)

    Published 2025
    “…</p><p><b>Results:</b> Globally, ACM burden showed significant declines from 1990 to 2021, with age-standardized rates decreasing by 22.5-37.1% across prevalence, mortality and disability measures. …”
  19. 60999

    Results from phylogenetic profile comparison of 635,628 pairs of proteins chosen from among a subset of 1,191 yeast proteins by Raja Jothi (31820)

    Published 2011
    “…The relative performances of all but one (BAE4) reference sets of genomes for yeast are almost the same as that for . A gradual decrease in performance can be noticed as the fraction of eukaryotic genomes in the reference set increases (BAE4, BAE5, BAE6, AE, E), which is counter-intuitive considering the fact that one would hope to see an improved performance on adding more eukaryotic genomes. …”
  20. 61000

    Data_Sheet_2_Role of Downregulation and Phosphorylation of Cofilin in Polarized Growth, MpkA Activation and Stress Response of Aspergillus fumigatus.PDF by Xiaodong Jia (783460)

    Published 2018
    “…Expression of non-phosphorylated cofilin with a mutation of S5A had little impacts on A. fumigatus, whereas expression of a mimic-phosphorylated cofilin with a mutation of S5E resulted in inhibited growth, increased phospho-MpkA level, and decreased pathogenicity. …”